Abstract
Abstract A new contrast medium Cardio-Conray (a 2:1 mixture of meglumine iothalamate and sodium iothalamate) has been utilised for 928 angiocardiographic and aortographic injections in 458 patients. The angiographic quality was very satisfactory: there were no major adverse reactions (one death of doubtful attribution). Evidence is presented which suggests that a contrast medium of low sodium content—such as Cardio-Conray—should, in general, be used in all central angiocardiographies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
